JOINDER AND COUNTERPART SIGNATURE PAGE OF REGISTRATION RIGHTS AGREEMENT OF LIPIMETIX DEVELOPMENT, INC.Joinder and Counterpart Signature • August 14th, 2017 • Capstone Therapeutics Corp. • Pharmaceutical preparations
As of August 11, 2017, the undersigned has executed this counterpart signature to the Registration Rights Agreement entered into as of August 25, 2016, by and among the Company, the Common Holders and the Investors (as such terms are defined therein), and does hereby agree to be bound by all of the obligations as an “Investor” thereunder and the terms thereof as though originally an Investor thereto.
